- Home
- ENTA vs AMPY Comparison
ENTA vs AMPY Comparison
Compare ENTA & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- AMPY
- Stock Information
- Founded
- ENTA 1995
- AMPY 2011
- Country
- ENTA United States
- AMPY United States
- Employees
- ENTA N/A
- AMPY N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- ENTA Health Care
- AMPY Energy
- Exchange
- ENTA Nasdaq
- AMPY Nasdaq
- Market Cap
- ENTA 154.0M
- AMPY 157.7M
- IPO Year
- ENTA 2013
- AMPY 2011
- Fundamental
- Price
- ENTA $5.59
- AMPY $3.79
- Analyst Decision
- ENTA Buy
- AMPY Strong Buy
- Analyst Count
- ENTA 4
- AMPY 3
- Target Price
- ENTA $17.25
- AMPY $10.00
- AVG Volume (30 Days)
- ENTA 228.9K
- AMPY 580.6K
- Earning Date
- ENTA 05-05-2025
- AMPY 03-05-2025
- Dividend Yield
- ENTA N/A
- AMPY N/A
- EPS Growth
- ENTA N/A
- AMPY N/A
- EPS
- ENTA N/A
- AMPY 0.31
- Revenue
- ENTA $66,590,999.00
- AMPY $294,680,100.00
- Revenue This Year
- ENTA N/A
- AMPY $26.99
- Revenue Next Year
- ENTA N/A
- AMPY $21.93
- P/E Ratio
- ENTA N/A
- AMPY $12.21
- Revenue Growth
- ENTA N/A
- AMPY 1.72
- 52 Week Low
- ENTA $4.71
- AMPY $3.54
- 52 Week High
- ENTA $17.80
- AMPY $8.15
- Technical
- Relative Strength Index (RSI)
- ENTA 31.66
- AMPY 35.80
- Support Level
- ENTA $5.65
- AMPY $3.72
- Resistance Level
- ENTA $5.96
- AMPY $4.06
- Average True Range (ATR)
- ENTA 0.36
- AMPY 0.18
- MACD
- ENTA -0.15
- AMPY 0.05
- Stochastic Oscillator
- ENTA 4.77
- AMPY 18.75
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.